IL10 and adult T-cell leukemia/lymphoma: By evaluating the production of IL-10, we could also observe that IVIg, IgG from HCs, ACs, and ATLL patients could reduce the frequency of IL-10-producing B cells compared to mock conditions (Figure 4B and Supplementary Figure S5).